[1] Dupont B, Crew Brown HH, Westermann K, et al. Mycoses in AIDS. Med Mycol, 2000,38(Suppl 1) :259-267. [2] 温海,廖万清,吴建华.几株新生隐球菌聚合酶链反应指纹分型的观察.中华医学杂志,1997,77:782-783. [3] Perfect JR, Toffaletti DL, Rude TH. The gene encoding phosphoribosylaminirmidazole corboxylase(ADE2) is essential for growth of Cryptococcus neoformans in cerebrospinal fluid. Infect Immun, 1993,61:4446-4451. [4] Fristine SM, Misialek S, Toffaletti DL, et al. Biochemical role of the Cryptococcus neoformans ADE2 protein in fungal de novo purine biosynthesis. Arch Biochem Biophys, 1998, 351:123-134. [5] Sirawaraporn W, Cao M, Santi DW, et al. Cloning expression and characterization of Cryptococcus neoformans dihydrofolate reductase. J Biol Chem, 1993, 268:8888-8892. [6] Verweij PE, Figueroa J, Van Burik J, et al. Clinical applications of non culture based methods for the diagnosis and management of opportunistic and endemic mycoses. Med Mycol, 2000,38(Suppl 1):161-171. [7] Holdom MD, Lechenne B, Hay RJ, et al. Production and characterization of recombinant Aspergillus fumigatus Cu-Zn superoxide dismutase and its recognition by immune human.sera. J Clin Microbiol, 2000, 38:558-562. [8] Reiss E, Obayashi T, Orle K, et al. Non culture based diagnosis tests for mycotic infections. Med Mycol, 2000, 38(Suppl 1): 147-159. [9] Olsson M, Elvin K, Lofdahl S, et al. Detection of pneumocystis Carinii DNA in sputum and bronchoalveolar lavage samples by polymerase chain reaction. J Clin Microbiol, 1993,31:221-226. [10] Tamburrini E, Mencarini P, Visconti E, et al. Potential impact of pneumocystis genetic diversity on the molecular detection of the parasite in human host. FEMS Immunol Med Microbiol, 1998,22:123-128. [11] Gruda I, Milette D, Brother M, et al. Structure activity study of inhibition of amphotericin B (Fungizone) binding to sterols, toxicity to cells, and lethality to mice by esters of sucrose. Antimicrob Agents Chemother, 1991,35:24-28. [12] Martins MD, Lozano Chiu M, Rex JH. Declining rates of oropharyngeal candidiasis and carriage of Candida albicans associated with trends toward reduced rates of carriage of fluconazole resistant C.albicans in human immunodeficiency virus infected patients. Clin Infect Dis, 1998,27:1291-1294. [13] Valdez H, Gripshover BM, Salata RA, et al. Resolution of azole resistant oropharyngeal candidiasis after initiation of potent combination antiretroviral therapy. AIDS, 1998, 12:538-540. |